Regeneron Pharmaceuticals, Inc. (BIT:1REGN)
476.60
-5.00 (-1.04%)
Last updated: Aug 12, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of €49.70 billion as of August 14, 2025. Its market cap has decreased by -53.71% in one year.
Market Cap
49.70B
Enterprise Value
37.05B
Revenue
12.10B
Ranking
n/a
PE Ratio
13.09
Stock Price
€476.60
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 49.70B, an increase of 37,721.43%. That is a compound annual growth rate of 19.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 49.70B | -32.86% |
Dec 31, 2024 | 74.03B | -12.40% |
Dec 29, 2023 | 84.50B | 17.20% |
Dec 30, 2022 | 72.10B | 24.19% |
Dec 31, 2021 | 58.06B | 39.28% |
Dec 31, 2020 | 41.68B | 13.96% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
UniCredit | 106.56B |
Intesa Sanpaolo | 94.20B |
Enel SpA | 79.63B |
Ferrari | 68.06B |
Assicurazioni Generali | 50.57B |
Eni S.p.A. | 45.25B |
Leonardo S.p.a. | 26.47B |
Poste Italiane | 25.71B |